Lassa fever case in Germany highlights global travel hazards:
This article was originally published in Clinica
Executive Summary
A suspected case of Lassa fever in Germany, discovered in a Sierra Leone resident visiting the country, has been laboratory-confirmed by the Bernhard-Nocht-Institute of Tropical Medicine, in Hamburg. The case is being treated in isolation but, even though the risk of transmission of Lassa virus to co-passengers is, according to the WHO, "extremely low", the case has triggered an international contact-tracing exercise, highlighting the significant potential for disease transmission through international travel.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.